LexaGene Holdings Past Earnings Performance
Past criteria checks 0/6
LexaGene Holdings's earnings have been declining at an average annual rate of -14.5%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 74.5% per year.
Key information
-14.5%
Earnings growth rate
4.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 74.5% |
| Return on equity | -670.7% |
| Net Margin | -8,189.9% |
| Last Earnings Update | 30 Nov 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How LexaGene Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Nov 22 | 0 | -9 | 3 | 5 |
| 31 Aug 22 | 0 | -10 | 4 | 5 |
| 31 May 22 | 0 | -10 | 4 | 6 |
| 28 Feb 22 | 0 | -11 | 4 | 6 |
| 30 Nov 21 | 0 | -11 | 5 | 6 |
| 31 Aug 21 | 0 | -11 | 5 | 6 |
| 31 May 21 | 0 | -11 | 5 | 6 |
| 28 Feb 21 | 0 | -10 | 4 | 6 |
| 30 Nov 20 | 0 | -9 | 4 | 5 |
| 31 Aug 20 | 0 | -9 | 3 | 5 |
| 31 May 20 | 0 | -8 | 3 | 5 |
| 29 Feb 20 | 0 | -7 | 3 | 4 |
| 30 Nov 19 | 0 | -8 | 3 | 5 |
| 31 Aug 19 | 0 | -8 | 3 | 5 |
| 31 May 19 | 0 | -8 | 3 | 5 |
| 28 Feb 19 | 0 | -8 | 3 | 5 |
| 30 Nov 18 | 0 | -7 | 3 | 5 |
| 31 Aug 18 | 0 | -7 | 2 | 4 |
| 31 May 18 | 0 | -5 | 2 | 3 |
| 28 Feb 18 | 0 | -4 | 1 | 2 |
| 30 Nov 17 | 0 | -3 | 2 | 2 |
| 31 Aug 17 | 0 | -6 | 1 | 1 |
| 31 May 17 | 0 | -5 | 1 | 1 |
| 28 Feb 17 | 0 | -4 | 1 | 0 |
| 30 Nov 16 | 0 | -4 | 0 | 0 |
| 31 Aug 16 | 0 | 0 | 0 | 0 |
Quality Earnings: 5XS2 is currently unprofitable.
Growing Profit Margin: 5XS2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5XS2 is unprofitable, and losses have increased over the past 5 years at a rate of 14.5% per year.
Accelerating Growth: Unable to compare 5XS2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 5XS2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: 5XS2 has a negative Return on Equity (-670.69%), as it is currently unprofitable.